Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Regeneron Pharmaceuticals, Inc. REGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
83/100
6/7 Pass
SharesGrow Intrinsic Value
$1,711.01
+126.5%
Analyst Price Target
$862.74
+14.2%
Metric TTM (2025-03 – 2025-12)
Revenue $14.34B
Gross Profit $12.24B
Gross Margin 85.4%
Operating Income $3.58B
Net Income $4.5B
Net Margin 31.4%
EPS (Diluted) $41.56

People Also View

NVO
NVO
Novo Nordisk A/S
$39.32
+3.53%
 ALNY
ALNY
Alnylam Pharmaceuticals, Inc.
$339.41
+1.92%
 UTHR
UTHR
United Therapeutics Corporation
$578.54
+0.16%
 BGNE
BGNE
BeiGene, Ltd.
$184.71
+0.49%
 INCY
INCY
Incyte Corporation
$97.69
+2.24%
 IONS
IONS
Ionis Pharmaceuticals, Inc.
$76.76
+2.41%
 MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 BMRN
BMRN
BioMarin Pharmaceutical Inc.
$55.47
+1.08%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message